Graypoint LLC Bristol Myers Squibb CO Transaction History

Graypoint LLC

$1.35 Billion
Q1 2024

A detailed history of Graypoint LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Graypoint LLC holds 13,642 shares of BMY stock, worth $546,498. This represents 0.05% of its overall portfolio holdings.

Number of Shares

13,642

Previous 13,775 0.97%

Holding current value

$546,498

Previous $706,000 4.67%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $6,381 - $7,235	-133 Reduced 0.97%	13,642 $739,000
Q4 2023 Jan 29, 2024	BUY	$48.48 - $57.85 $89,591 - $106,906	1,848 Added 15.49%	13,775 $706,000
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $160,181 - $179,107	2,767 Added 30.21%	11,927 $692,000
Q2 2023 Jul 21, 2023	SELL	$63.71 - $70.74 $137,677 - $152,869	-2,161 Reduced 19.09%	9,160 $585,000
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $197 - $223	3 Added 0.03%	11,321 $784,000

Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $111,280 - $131,771	-1,625 Reduced 12.56%	11,318 $814,000
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $586 - $346,625	4,511 Added 53.5%	12,943 $920,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $42,192 - $46,468	581 Added 7.4%	8,432 $649,000
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $3,873 - $4,644	63 Added 0.81%	7,851 $573,000
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $6,650 - $7,752	-124 Reduced 1.57%	7,788 $486,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $76,092 - $89,132	-1,286 Reduced 13.98%	7,912 $468,000
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $48,042 - $52,317	776 Added 9.21%	9,198 $615,000
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $33,230 - $37,374	560 Added 7.12%	8,422 $532,000
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $16,167 - $18,320	280 Added 3.69%	7,862 $488,000
Q3 2020 Nov 02, 2020	BUY	$57.43 - $63.64 $153,108 - $169,664	2,666 Added 54.23%	7,582 $457,000
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $1,370 - $1,602	25 Added 0.51%	4,916 $289,000
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $226,942 - $329,800	4,891 New	4,891 $272,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account